166
Participants
Start Date
November 30, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
December 31, 2012
Imetelstat sodium
Imetelstat is administered at a dose of 300 mg/m2 on day one of a 21 day cycle.
Bevacizumab
Bevacizumab is administered at 15 mg/kg on day one of a 21 day cycle
Paclitaxel
Paclitaxel is administered at 90 mg/m2 on days one and eight of a 21 day cycle
Prohealth Associates, Lake Success
Stony Brook University, Stony Brook
Penn. State Univ., Hershey
Pinnacle Health, Harrisburg
Peninsula Cancer Institute, Newport News
Moses Cone Medical System, Greensboro
Carolinas Hematology/Oncology, Charlotte
Peachtree Hematology Oncology, Atlanta
Emory University, Atlanta
Northeast Georgia Medical Center, Gainesville
Northeast Georgia Cancer Care, Athens
Central Georgia Cancer Care, Macon
Summit Cancer Care, Savannah
Florida Oncology Associates, Jacksonville
H. Lee Moffitt Cancer Center, Tampa
Hematology Oncology Associates, Port Saint Lucie
Clearview Cancer Center, Huntsville
The West Clinic, Memphis
The Jones Clinic, Germantown
Montgomery Cancer Care, Mount Sterling
Case Western Reserve Univ., Cleveland
Indiana University, Indianapolis
Community Hospitals of Indiana, Indianapolis
Horizon Oncology Center, Lafayette
Michigan State University, East Lansing
Cancer Treatment Centers of America, Zion
Ingalls Memorial Hospital, Chicago
Rush University, Chicago
Mid Illinois Hematology & Oncology, Normal
Cancer Center of Kansas, Wichita
Mercy Physicians of Oklahoma, Oklahoma City
Cancer Care Associates, Tulsa
Scott & White Healthcare, Temple
Univ. Colorado at Denver, Aurora
Kootenai Medical Center, Post Falls
Northern Utah Associates, Ogden
New Mexico Cancer Center, Albuquerque
Memorial Miller Hospital, Long Beach
UC San Diego, San Diego
Desert Regional Comprehensive Cancer Center, Palm Springs
St. Joseph Hospital, Orange
Cancer Care Associates, Fresno
Alta Bates Summit Medical Center, Berkeley
Southbay Oncology Hematology Partners, Campbell
Redwood Regional Medical Group, Santa Rosa
Kaiser Northwest, Portland
Northwest Medical Specialties, Tacoma
Medical Oncology Associates, Spokane
Connecticut Oncology & Hematology, Torrington
Medical Oncology Hematology, Waterbury
Grand River Regional Cancer Centre, Kitchener
Stronach Regional Cancer Centre at Southlake, Newmarket
The Ottawa Hospital Cancer Centre, Ottawa
Sunnybrook Health Services Centre, Toronto
McGill University, Montreal
Lead Sponsor
Geron Corporation
INDUSTRY